Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
407 studies found for:    metabolic syndrome AND syndrome X AND insulin resistance AND diabetes
Show Display Options
Rank Status Study
41 Suspended Insulin Sensitivity in Men With the Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Procedure: intravenous glucose tolerance test;   Drug: testosterone;   Drug: anastrozole;   Drug: goserelin acetate implant;   Procedure: aerobic capacity (VO2 Max);   Procedure: MRI;   Procedure: muscle biopsy;   Procedure: measurement of resting metabolic rate (energy expenditure);   Procedure: Dual energy x-ray absorptiometry;   Procedure: Fasting oral glucose tolerance test
42 Recruiting Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome
Conditions: Type 1 Diabetes;   Metabolic Syndrome
Intervention: Behavioral: Nutritional Counseling
43 Completed FTO rs9939609 and PPARy rs1801282 Polymorphisms in Mexican Adolescents
Conditions: Metabolic Syndrome;   Insulin Resistance
Intervention:
44 Completed Niacin, N-3 Fatty Acids and Insulin Resistance
Conditions: Metabolic Syndrome;   Hypertriglyceridemia
Interventions: Drug: omega-3 acid ethyl esters;   Drug: extended release niacin;   Drug: placebo;   Drug: combined treatment
45 Recruiting Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome
Conditions: Metabolic Syndrome x;   Glucose Metabolism Disorders;   Dyslipidemias;   Obesity
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Live Akk 9;   Dietary Supplement: Live Akk 10;   Dietary Supplement: Killed Akk
46 Completed The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
Condition: Metabolic Syndrome x
Interventions: Drug: Study drugs: Metformin and fenofibrate;   Drug: Study Drug: Metformin;   Drug: Study Drug: fenofibrate;   Drug: Metformin and Fenofibrate placebo
47 Not yet recruiting Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause
Condition: Metabolic Syndrome
Interventions: Behavioral: exercise;   Drug: Hormone treatment
48 Completed
Has Results
Study of Sildenafil Citrate on Insulin Resistance in African American
Conditions: Metabolic Syndrome;   Obesity
Interventions: Drug: Sildenafil;   Drug: Placebo
49 Unknown  Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention: Procedure: Glucose tolerance test
50 Completed
Has Results
Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
Conditions: Type 2 Diabetes;   Insulin Resistance;   Metabolic Syndrome
Interventions: Drug: metformin;   Drug: pioglitazone;   Drug: Placebo
51 Completed Novel Dietary Interventions for Treating Insulin Resistance
Conditions: Insulin Resistance;   Obesity;   Metabolic Syndrome
Interventions: Dietary Supplement: Fish Oil;   Dietary Supplement: Polyphenol Capsules;   Dietary Supplement: Corn Oil Capsules;   Dietary Supplement: Corn starch capsules;   Other: Reduced glycemic index bread products;   Other: Market variety bread products
52 Completed
Has Results
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Conditions: Metabolic Syndrome;   Bipolar Depression;   Insulin Resistance
Intervention: Drug: Pioglitazone
53 Completed Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome
Condition: Pre Diabetes
Interventions: Dietary Supplement: BGG;   Other: Placebo
54 Active, not recruiting LUPS-Lipids and Glucose Under Prospective Surveillance
Conditions: Metabolic Syndrome, Syndrome X, MetS,;   Diabetes Mellitus, Non-Insulin-Dependent
Intervention:
55 Completed Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
Conditions: Metabolic Syndrome;   Impaired Glucose Tolerance;   Insulin Resistance;   Endothelial Dysfunction
Interventions: Drug: L-arginine;   Drug: Placebo
56 Unknown  Genetic Assessment of the Patients With Metabolic Syndrome
Condition: Metabolic Syndrome
Intervention:
57 Terminated
Has Results
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome;   Hyperlipidemia;   Obesity;   Hypertension
Intervention: Drug: Etanercept
58 Completed The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome
Conditions: Metabolic Syndrome;   Type 2 Diabetes;   Cardiovascular Disease
Interventions: Dietary Supplement: Walnuts;   Dietary Supplement: Control
59 Unknown  Metabolic Syndrome in an Elderly Population is More Linked to Insulin Resistance Than to Obesity
Condition: Metabolic Syndrome in the Elderly
Intervention:
60 Active, not recruiting PilAm Go4Health Weight Loss Program to Prevent Heart Disease
Conditions: Insulin Resistance,;   Metabolic Syndrome;   Type 2 Diabetes
Intervention: Behavioral: PilAm Go4Health Weight-loss Program

First Page    Show previous page of results Previous Page (21-40) Studies Shown (41-60) Next Page (61-80) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.